These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 30335833)
1. Antiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study. Hsu YH; Yen YC; Lin YC; Sung LC PLoS One; 2018; 13(10):e0206011. PubMed ID: 30335833 [TBL] [Abstract][Full Text] [Related]
2. Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula. Chang TI; Chen CH; Hsieh HL; Chen CY; Hsu SC; Cheng HS; Huang WC; Sue YM; Hsu YH; Lin FY; Shih CM; Lin SJ; Huang PH; Liu CT Sci Rep; 2020 Jul; 10(1):12135. PubMed ID: 32699337 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Outcomes with Arteriovenous Fistula and Arteriovenous Graft for Vascular Access in Hemodialysis: A Prospective Cohort Study. Park HS; Kim WJ; Kim YK; Kim HW; Choi BS; Park CW; Kim YO; Yang CW; Kim YL; Kim YS; Kang SW; Kim NH; Jin DC Am J Nephrol; 2016; 43(2):120-8. PubMed ID: 27022896 [TBL] [Abstract][Full Text] [Related]
4. Patency of arteriovenous fistula for dialysis improbe with topical spraygel heparin. Stuard S; Belcaro G; Dugall M; Cesarone MR; Hosoi M; Errichi BM; Ippolito E; Bavera P; Cornelli U Panminerva Med; 2010 Jun; 52(2 Suppl 1):33-6. PubMed ID: 20657532 [TBL] [Abstract][Full Text] [Related]
5. Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients. Doi S; Masaki T; Shigemoto K; Harada S; Yorioka N Ther Apher Dial; 2008 Jun; 12(3):232-6. PubMed ID: 18503701 [TBL] [Abstract][Full Text] [Related]
6. Risk of arteriovenous fistula failure associated with hypnotic use in hemodialysis patients: a nested case-control study. Lin CF; Chiou HY; Chang YH; Liu JC; Hung YN; Chuang MT; Chien LN Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):889-97. PubMed ID: 26799147 [TBL] [Abstract][Full Text] [Related]
7. Effects of Antiplatelet Medication on Arteriovenous Fistula Patency After Surgical Thrombectomy. Yeh CH; Huang TS; Wang YC; Huang PF; Huang TY; Chen TP; Yin SY; Yu YW Curr Vasc Pharmacol; 2016; 14(4):353-9. PubMed ID: 26924326 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement. Jackson RS; Sidawy AN; Amdur RL; Khetarpal A; Macsata RA J Vasc Surg; 2011 Dec; 54(6):1706-12. PubMed ID: 21840155 [TBL] [Abstract][Full Text] [Related]
9. Role of antiplatelet therapy in the durability of hemodialysis access. Locham S; Beaulieu RJ; Dakour-Aridi H; Nejim B; Malas MB J Nephrol; 2018 Aug; 31(4):603-611. PubMed ID: 29730781 [TBL] [Abstract][Full Text] [Related]
10. Patency in arteriovenous grafts in hemodialysis patients. Mousa AY; Patterson W; Abu-Halimah S; Hass SM; Alhalbouni S; Sadek BT; Nanjundappa A; Modak A; Stone PA; Emmett M; AbuRahma AF Vasc Endovascular Surg; 2013 Aug; 47(6):438-43. PubMed ID: 23853221 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of outcomes with permanent vascular access in an elderly Korean population based on the National Health Insurance Service database. Kim H; Park HS; Ban TH; Yang SB; Kwon YJ; Hemodial Int; 2023 Jul; 27(3):249-258. PubMed ID: 36943638 [TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis. Palmer SC; Di Micco L; Razavian M; Craig JC; Ravani P; Perkovic V; Tognoni G; Graziano G; Jardine M; Pellegrini F; Nicolucci A; Webster A; Strippoli GF Am J Kidney Dis; 2013 Jan; 61(1):112-22. PubMed ID: 23022428 [TBL] [Abstract][Full Text] [Related]
14. Comparison of vascular access patency and patient survival between native arteriovenous fistula and synthetic arteriovenous graft according to age group. Choi J; Ban TH; Choi BS; Baik JH; Kim BS; Kim YO; Park CW; Yang CW; Jin DC; Park HS Hemodial Int; 2020 Jul; 24(3):309-316. PubMed ID: 32372545 [TBL] [Abstract][Full Text] [Related]
15. An Outcomes Comparison of Native Arteriovenous Fistulae, Polytetrafluorethylene Grafts, and Cryopreserved Vein Allografts. Jadlowiec CC; Lavallee M; Mannion EM; Brown MG Ann Vasc Surg; 2015 Nov; 29(8):1642-7. PubMed ID: 26319146 [TBL] [Abstract][Full Text] [Related]
16. Vascular access profile in maintenance hemodialysis patients. Gowda A; Pavan M; Babu K Iran J Kidney Dis; 2014 May; 8(3):218-24. PubMed ID: 24878945 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis. Chen FA; Chien CC; Chen YW; Wu YT; Lin CC PLoS One; 2016; 11(11):e0166362. PubMed ID: 27832203 [TBL] [Abstract][Full Text] [Related]